Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19.
Content based on a CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/conference-coverage/covid19-2020
Director, International HIV Training Center
Professor of Medicine
University of Chicago
Senior Scientific Director
Executive Vice President
This program has been made available online.
Download free slides from CCO reviewing the latest data and guidance on COVID-19 symptoms and the prevalence and duration of natural immunity
Download free slides from CCO reviewing the latest data and guidance on COVID-19 risk and management in special populations and persons with comorbidities
Download free slides from CCO reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis and transmission
Download free slides from CCO reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents